Table 1 Baseline characteristics of included patients who received more than three intravitreal conbercept injections for AMD and DME.
Total | AMD | DME | |
|---|---|---|---|
Patient (eyes) | 49 (98) | 38 (72) | 11 (22) |
Injection/Non-injection (eyes) | 49/49 | 38/38 | 11/11 |
Mean age | 66 ± 9 | 69 ± 7 | 57 ± 9 |
Sex (male:female) | 32:17 | 25:13 | 7:4 |
Injection/Non-injection (p) | Injection/Non-injection (p) | Injection/Non-injection (p) | |
Baseline IOP (mmHg) | 15.3 ± 2.8/15.9 ± 2.9 (0.301) | 15.2 ± 2.9/15.8 ± 3.0 (0.357) | 15.6 ± 2.5/16.1 ± 2.9 (0.658) |
Baseline RNFL thickness (μm) | 108.9 ± 24.0/109.9 ± 31.4 (0.863) | 101.9 ± 13.8/101.3 ± 11.7 (0.823) | 133.0 ± 35.0/139.6 ± 54.6 (0.738) |
